Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-02 Option Award | 2024-02-06 4:27 pm | N/A N/A | Mallinckrodt plc | Richardson Peter C EVP & Chief Scientific Officer | 10,258 | $0 | 10,258 (Direct) | View | |
| 2023-11-14 Disposition | 2023-11-16 4:14 pm | N/A N/A | Mallinckrodt plc | MNKTQ | Richardson Peter C EVP & Chief Scientific Officer | 75,091 | $0 | 0 (Direct) | View |
| 2023-06-30 Disposition | 2023-07-05 6:17 pm | N/A N/A | Mallinckrodt plc | MNK | Richardson Peter C EVP & Chief Scientific Officer | 127,861 | $0 | 0 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-05 7:05 pm | N/A N/A | Mallinckrodt plc | MNK | Richardson Peter C EVP & Chief Scientific Officer | 127,861 | $0 | 127,861 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 1:31 pm | N/A N/A | Mallinckrodt plc | MNK | Richardson Peter C EVP & Chief Scientific Officer | 75,091 | $0 | 75,091 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:27 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks | 128,216 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:27 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks | 50,613 | $5.6 | 0 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 36,199 | $4.42 | 105,236 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 69,037 | $0 | 105,236 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-28 8:40 pm | N/A 2031-04-26 | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 59,179 | $0 | 59,179 (Direct) | View |